Universities of Birmingham and Warwick form spinout company, 4D Medicine Ltd, to take new family of biomedical 3D printing resins to market
The Universities of Birmingham and Warwick have created a new spinout company, 4D Medicine Ltd, to commercialise a new class of materials – liquid resins that can be printed into solid 3D scaffolds to help patients recover from major medical procedures more quickly.
The work being done at University of Warwick, in collaboration with Iceni Diagnostics, around developing a new approach to rapid coronavirus diagnostics has been featured on the BBC. On Thursday 25 June, BBC Midlands interviewed Professor Gibson and members of his team - a feature on this can be read on the BBC News web pages. You can also see the news report video here.
New diagnostic tool for rapid detection of Coronavirus being developed by University of Warwick and Partners
Coronavirus diagnostics currently require centralised facilities and collection/distribution of swabs and results are ‘next day’. A new diagnostic tool being developed by the University of Warwick and its partner Iceni Diagnostics may allow on-the-spot detection of Coronavirus infection, without facilities using a simple disposal device.
University of Warwick spin-out Sarissa Biomedical raises £1.2m for new test to diagnose stroke victims
This year's ICURe programme is open for applications - and because it is online, it's more accessible, particularly to applicants who may not be able to travel
The Royal Society of Chemistry Energy Sector is pleased to announce Dr Harriotte Jessica Pereira as the winner of its PhD Thesis Award Competition 2019 for her PhD Thesis entitled Nanostructured Copper Window and Reflective Electrodes for Organic Photovoltaics.
Verdel is a UK-based company pushing the boundaries of complex sample analysis using innovative Two-Dimensional Mass Spectrometry (2DMS) technology
Neste and Mirova back Recycling Technologies to accelerate transition to circular economy for plastic
Our investor days will showcase 15 new University Spinout companies who have participated in the award winning Innovate UK funded ICURe (Innovation to Commercialisation of University Research) programme and are now seeking early-stage funding and entrepreneurial managers.
A drug designed to tackle diabetes could also be repurposed as the first treatment to prevent miscarriage by targeting the lining of the womb itself, according to a clinical trial led by the University of Warwick